News Conference News ESC 2025 Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF Michael O'Riordan August 29, 2025
News Opinion Editor's Corner ESC 2025 What’s Going to Be Hot at ESC Congress 2025? Michael O'Riordan August 25, 2025
News Daily News Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC Yael L. Maxwell August 18, 2025
News Daily News HF Risks Stick Around Even When Ejection Fraction Improves Todd Neale August 01, 2025
News Daily News Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data L.A. McKeown July 24, 2025
News Daily News FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF Caitlin E. Cox July 14, 2025
News Daily News Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients Michael O'Riordan June 16, 2025
News Conference News ESC Heart Failure 2025 TITRATE-HF: Use of GDMT for HF Is Getting Better but Still Not Ideal Todd Neale May 21, 2025
News Conference News ESC Heart Failure 2025 Finerenone May Cut Early Readmissions in HF Patients Todd Neale May 21, 2025
News Conference News ESC Heart Failure 2025 No Additional Gain in Quality of Life With Dapagliflozin on Top of TAVI Todd Neale May 20, 2025
News Conference News ESC Heart Failure 2025 Cardiology Consults Tied to Better Outcomes in Patients With HF Todd Neale May 19, 2025
News Conference News ESC Heart Failure 2025 HELIOS-B: Additional Data Affirm Benefits of Vutrisiran for ATTR-CM Todd Neale May 19, 2025
News Daily News Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study Todd Neale May 09, 2025
News Daily News STRONG-HF Analysis Quantifies Gains From Rapid Uptake of GDMT Todd Neale May 08, 2025
News Conference News ACC 2025 FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints L.A. McKeown April 03, 2025